Researcher urges Health Canada to suspend "unethical" diabetes drug trial.
Laura
L
Eggertson
D002170:Canada; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006801:Humans; D009203:Myocardial Infarction / Q000139:chemically induced; D000077154:Rosiglitazone; D056737:Safety-Based Drug Withdrawals; D045162:Thiazolidinediones / Q000009:adverse effects* / Q000627:therapeutic use
D045162:Thiazolidinediones; D000077154:Rosiglitazone